A Study of Neurophysiologic Changes in Individuals With Parkinson's Disease
Completed
Conditions studied: Parkinson's Disease, Parkinsonian Syndrome
In brief
The goal of this study is to investigate neurophysiologic tests that have the potential of serving as screening tools for Parkinson's disease. These neurophysiologic tests will be administered to individuals with Parkinson's disease and parkinsonian syndrome and validated against a healthy control population. Specifically, this study will look at changes in motor function, cognitive function, handwriting, speech, and olfactory function in individuals with Parkinson's disease, individuals at risk for Parkinson's disease and healthy controls.
Key facts
- Study ID
- NCT00117195
- Run by
- Institute for Neurodegenerative Disorders
- People needed
- 620
- Starts
- 2003-05-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2012-02-09
Who can join
Age: 22 and older. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- As a participant with PD or PS:
- Age >21
- Clinical diagnosis of PD or PS (at least two of the three cardinal symptoms: resting tremor, rigidity, bradykinesia) and a clinical response to dopaminergic therapy
- For Healthy Control:
- Age >21
You may not qualify if…
- As a participant with PD or PS:
- Any other concomitant neurologic condition likely to interfere with handwriting, use of the computer, or other motor tasks tested in this study (e.g. stroke, demyelinating disease, visual loss)
- For Healthy Control:
- Any indication of parkinsonism on examination
- Any other concomitant neurologic condition likely to interfere with handwriting, use of the computer, or other motor tasks (e.g. stroke, demyelinating disease, visual loss)
Where it is running
- Institute for Neurodegenerative Disorders — New Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.